vs

Side-by-side financial comparison of Globe Life (GL) and Teradyne (TER). Click either name above to swap in a different company.

Globe Life is the larger business by last-quarter revenue ($1.6B vs $1.3B, roughly 1.2× Teradyne). Teradyne runs the higher net margin — 31.1% vs 17.3%, a 13.8% gap on every dollar of revenue. On growth, Teradyne posted the faster year-over-year revenue change (87.0% vs 5.3%). Over the past eight quarters, Teradyne's revenue compounded faster (32.6% CAGR vs 4.1%).

Globe Life Inc. (GL) is an American financial services holding company listed on the New York Stock Exchange which operates through its wholly owned subsidiaries providing life insurance, annuity, and supplemental health insurance products. The company is based in McKinney, Texas.

Teradyne, Inc. is an American automatic test equipment (ATE) designer and manufacturer based in North Reading, Massachusetts. Its high-profile customers include Samsung, Qualcomm, Intel, Analog Devices, Texas Instruments and IBM.

GL vs TER — Head-to-Head

Bigger by revenue
GL
GL
1.2× larger
GL
$1.6B
$1.3B
TER
Growing faster (revenue YoY)
TER
TER
+81.7% gap
TER
87.0%
5.3%
GL
Higher net margin
TER
TER
13.8% more per $
TER
31.1%
17.3%
GL
Faster 2-yr revenue CAGR
TER
TER
Annualised
TER
32.6%
4.1%
GL

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
GL
GL
TER
TER
Revenue
$1.6B
$1.3B
Net Profit
$270.5M
$398.9M
Gross Margin
60.9%
Operating Margin
36.9%
Net Margin
17.3%
31.1%
Revenue YoY
5.3%
87.0%
Net Profit YoY
EPS (diluted)
$3.39
$2.53

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GL
GL
TER
TER
Q1 26
$1.6B
$1.3B
Q4 25
$1.5B
$1.1B
Q3 25
$1.5B
$769.2M
Q2 25
$1.5B
$651.8M
Q1 25
$1.5B
$685.7M
Q4 24
$1.5B
$752.9M
Q3 24
$1.5B
$737.3M
Q2 24
$1.4B
$729.9M
Net Profit
GL
GL
TER
TER
Q1 26
$270.5M
$398.9M
Q4 25
$266.1M
$257.2M
Q3 25
$387.8M
$119.6M
Q2 25
$252.7M
$78.4M
Q1 25
$254.6M
$98.9M
Q4 24
$255.2M
$146.3M
Q3 24
$303.0M
$145.6M
Q2 24
$258.4M
$186.3M
Gross Margin
GL
GL
TER
TER
Q1 26
60.9%
Q4 25
57.2%
Q3 25
58.4%
Q2 25
57.2%
Q1 25
60.6%
Q4 24
59.4%
Q3 24
26.1%
59.2%
Q2 24
23.3%
58.3%
Operating Margin
GL
GL
TER
TER
Q1 26
36.9%
Q4 25
21.7%
27.1%
Q3 25
31.5%
18.9%
Q2 25
21.2%
13.9%
Q1 25
21.4%
17.6%
Q4 24
21.3%
20.4%
Q3 24
26.3%
20.6%
Q2 24
23.5%
28.8%
Net Margin
GL
GL
TER
TER
Q1 26
17.3%
31.1%
Q4 25
17.5%
23.7%
Q3 25
25.6%
15.5%
Q2 25
17.1%
12.0%
Q1 25
17.2%
14.4%
Q4 24
17.4%
19.4%
Q3 24
20.8%
19.8%
Q2 24
17.9%
25.5%
EPS (diluted)
GL
GL
TER
TER
Q1 26
$3.39
$2.53
Q4 25
$3.28
$1.62
Q3 25
$4.73
$0.75
Q2 25
$3.05
$0.49
Q1 25
$3.01
$0.61
Q4 24
$3.00
$0.89
Q3 24
$3.44
$0.89
Q2 24
$2.83
$1.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GL
GL
TER
TER
Cash + ST InvestmentsLiquidity on hand
$183.8M
$241.9M
Total DebtLower is stronger
$0
Stockholders' EquityBook value
$6.1B
Total Assets
$4.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GL
GL
TER
TER
Q1 26
$183.8M
$241.9M
Q4 25
$314.7M
$293.8M
Q3 25
$62.8M
$272.7M
Q2 25
$116.7M
$339.3M
Q1 25
$134.1M
$475.6M
Q4 24
$85.0M
$553.4M
Q3 24
$100.5M
$510.0M
Q2 24
$100.6M
$421.9M
Total Debt
GL
GL
TER
TER
Q1 26
$0
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Stockholders' Equity
GL
GL
TER
TER
Q1 26
$6.1B
Q4 25
$6.0B
$2.8B
Q3 25
$5.7B
$2.7B
Q2 25
$5.4B
$2.8B
Q1 25
$5.4B
$2.8B
Q4 24
$5.3B
$2.8B
Q3 24
$4.6B
$2.9B
Q2 24
$5.2B
$2.7B
Total Assets
GL
GL
TER
TER
Q1 26
$4.4B
Q4 25
$30.8B
$4.2B
Q3 25
$30.5B
$4.0B
Q2 25
$29.8B
$3.8B
Q1 25
$29.7B
$3.7B
Q4 24
$29.1B
$3.7B
Q3 24
$29.6B
$3.8B
Q2 24
$28.3B
$3.6B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GL
GL
TER
TER
Operating Cash FlowLast quarter
$265.1M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
0.66×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GL
GL
TER
TER
Q1 26
$265.1M
Q4 25
$350.6M
$281.6M
Q3 25
$306.0M
$49.0M
Q2 25
$307.9M
$182.1M
Q1 25
$431.9M
$161.6M
Q4 24
$336.9M
$282.6M
Q3 24
$340.6M
$166.3M
Q2 24
$374.1M
$216.1M
Free Cash Flow
GL
GL
TER
TER
Q1 26
Q4 25
$330.1M
$218.8M
Q3 25
$208.7M
$2.4M
Q2 25
$295.0M
$131.7M
Q1 25
$420.1M
$97.6M
Q4 24
$321.9M
$225.2M
Q3 24
$311.3M
$114.4M
Q2 24
$356.5M
$171.2M
FCF Margin
GL
GL
TER
TER
Q1 26
Q4 25
21.7%
20.2%
Q3 25
13.8%
0.3%
Q2 25
19.9%
20.2%
Q1 25
28.4%
14.2%
Q4 24
22.0%
29.9%
Q3 24
21.4%
15.5%
Q2 24
24.8%
23.5%
Capex Intensity
GL
GL
TER
TER
Q1 26
Q4 25
1.3%
5.8%
Q3 25
6.4%
6.1%
Q2 25
0.9%
7.7%
Q1 25
0.8%
9.3%
Q4 24
1.0%
7.6%
Q3 24
2.0%
7.0%
Q2 24
1.2%
6.1%
Cash Conversion
GL
GL
TER
TER
Q1 26
0.66×
Q4 25
1.32×
1.09×
Q3 25
0.79×
0.41×
Q2 25
1.22×
2.32×
Q1 25
1.70×
1.63×
Q4 24
1.32×
1.93×
Q3 24
1.12×
1.14×
Q2 24
1.45×
1.16×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GL
GL

Life premium$853.2M55%
Health premium$416.9M27%
Other$289.5M19%

TER
TER

Segment breakdown not available.

Related Comparisons